Form 10-Q SK Growth Opportunities For: Mar 31
http://archive.fast-edgar.com/20240515/AS22I22CLZ22P29222962CY23CFTC222Y262
Filed on: May 15, 2024
Form 144 ASIAFIN HOLDINGS CORP. Filed by: SEE UNICORN VENTURES SDN BHD
http://archive.fast-edgar.com/20240515/AF2O422CZC2RN9QZ2U2G2ZY2EQAUZZ22Z262
Filed on: May 15, 2024
Form 4 BIOCRYST PHARMACEUTICALS For: May 14 Filed by: Doyle Anthony
http://archive.fast-edgar.com/20240515/AQZ2W22CSC2232TK222U2WZ2LHFFW228Z262
Filed on: May 15, 2024
Form 8-K UNITED STATES ANTIMONY For: May 15
0000101538false00001015382024-05-152024-05-15iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) May 15, 2024
UNITED STATES ANTIMONY CORPORATION
(Exact name of registrant as specified in its charter)
Montana
001-08675
81-0305822
(State or other jurisdiction of... (continue reading...)
Form 4 BIOCRYST PHARMACEUTICALS For: May 14 Filed by: Thackray Helen M.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form SC 13D/A ADAMS DIVERSIFIED EQUITY Filed by: Saba Capital Management, L.P.
-
Form 10-Q Venus Concept Inc. For: Mar 31
-
Form 10-Q TREVENA INC For: Mar 31
-
Form 8-K ATAI Life Sciences N.V. For: May 14
-
Form 6-K Sportradar Group AG For: May 15
-
Form 8-K Adaptimmune Therapeutics For: May 14
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Galson Steven K
-
Form 8-K BurgerFi International, For: May 15
-
Form 8-K Guerrilla RF, Inc. For: May 15
-
Form 13F-HR Arias Resource Capital For: Mar 31
-
Form 6-K Ayr Wellness Inc. For: May 15
-
Form 8-K Acurx Pharmaceuticals, For: May 15
-
Form 8-K Zapata Computing Holding For: May 15
-
Form 10-Q Volato Group, Inc. For: Mar 31
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Barnes Alane P
-
Form 8-K Edible Garden AG Inc For: May 15
-
Form 8-K BIO-PATH HOLDINGS, INC. For: May 15
-
Form 13F-NT Bank of Singapore Ltd For: Mar 31
-
Form 20-F Xinyuan Real Estate Co., For: Dec 31
-
Form 13F-HR ABG Innovation Capital For: Mar 31
-
Form 8-K Volato Group, Inc. For: May 15
-
Form 13F-HR Fullerton Fund Managemen For: Mar 31
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Stonehouse Jon P
-
Form 10-Q Katapult Holdings, Inc. For: Mar 31
-
Form 6-K ONCOLYTICS BIOTECH INC For: May 15
-
Form 8-K Olema Pharmaceuticals, For: May 15
-
Form 8-K TREVENA INC For: May 15
-
Form 8-K Venus Concept Inc. For: May 15
-
Form 6-K RADCOM LTD For: May 15
-
Form 8-K Cabaletta Bio, Inc. For: May 15
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Gayer Charles K
-
Form 13F-HR MUFG Securities EMEA For: Mar 31
-
Form 6-K Flex LNG Ltd. For: May 15
-
Form 6-K COMPUGEN LTD For: May 15
-
Form 8-K Perspective Therapeutics For: May 15
-
Form 10-K Prestige Consumer Health For: Mar 31
-
Form 13F-HR Fundsmith LLP For: Mar 31
-
Form 10-Q PSQ Holdings, Inc. For: Mar 31
-
Form 8-K Predictive Oncology Inc. For: May 15
-
Form 8-K Katapult Holdings, Inc. For: May 15
-
Form 8-K DecisionPoint Systems, For: May 15
-
Form 13F-NT Quilter Cheviot Internat For: Mar 31
-
Form 10-12B/A Inhibrx Biosciences,
-
Form 10-Q Eledon Pharmaceuticals, For: Mar 31
-
Form 10-Q Sagimet Biosciences Inc. For: Mar 31
-
Form 10-Q DecisionPoint Systems, For: Mar 31
-
Form 8-K Plutonian Acquisition For: May 15
-
Form 8-K Renalytix plc For: May 15
-
Form 6-K Kenon Holdings Ltd. For: May 15
-
Form 13F-HR ABG-WTT Global Life Scie For: Mar 31
